文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

英国犬源大肠杆菌ST410共携带blaNDM-5、blaCMY-42与blaTEM-190

Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

作者提示伴随耐药基因可能共选择碳青霉烯酶基因。

要点

  • 犬源ST410大肠杆菌可同时携带blaNDM-5、blaCMY-42与blaTEM-190。
  • blaNDM-5位于染色体整合的100 kb IncF质粒,另含mrx、sul1、ant1、dfrA。
  • 伴侣动物中碳青霉烯酶基因存在共选择与潜在传播风险。

核心结论

  • 尽管伴侣动物使用碳青霉烯类受限,blaCMY-42等耐药基因共存可能导致该群体中碳青霉烯酶基因被共选择。
  • 需进一步研究携带重要耐药基因的质粒在人与伴侣动物间的选择与流动。

研究设计与样本

  • 对氟喹诺酮和/或氨基糖苷类和/或头孢菌素敏感性降低的临床分离株开展调查,并对唯一目标分离株做Illumina/Nanopore全基因组组装。
  • 筛查共涉及191株革兰阴性分离株,检出1株ST410大肠杆菌(CARB35,1/191,0.5%)。

主要发现

  • CARB35分离自一只史宾格犬的伤口,携带已知碳青霉烯耐药基因blaNDM-5。
  • blaNDM-5位于染色体上整合的100 kb IncF质粒,该质粒还携带mrx、sul1、ant1和dfrA。
  • 该分离株另含blaCMY-42与blaTEM-190,分别位于IncI1和IncFII两个独立质粒,与意大利和缅甸的公开质粒序列同源。

关键数值与推荐

  • 碳青霉烯酶基因blaNDM-5位于染色体整合的100 kb IncF质粒。
  • blaCMY-42位于IncI1质粒,blaTEM-190位于IncFII质粒。
  • CRGNB在送检犬标本中的检出比例为1/191(0.5%)。

临床怎么用

  • 对伴侣动物伤口分离的碳青霉烯耐药革兰阴性菌应关注碳青霉烯酶基因与共选择质粒背景。
  • 兽医诊疗中分离到多重耐药菌时,宜结合基因型检测评估人兽共患传播风险。

局限性

  • 仅来自单一诊断实验室、34家兽医诊所的191株革兰阴性分离株,样本量有限。
  • 仅对敏感性降低的分离株进行碳青霉烯酶筛查,未覆盖全部革兰阴性菌。
  • 未评估人—动物间质粒传播的直接证据,结论为提示性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: Carbapenemase-producing Enterobacteriaceae (CPE) are a public health threat, and have been found in humans, animals and the environment. Carbapenems are not authorized for use in EU or UK companion animals, and the prevalence of carbapenem-resistant Gram-negative bacilli (CRGNB) in this population is unknown. METHODS: We investigated CRGNB isolated from animal specimens received by one diagnostic laboratory from 34 UK veterinary practices (September 2015-December 2016). Any Gram-negative isolates from clinical specimens showing reduced susceptibility to fluoroquinolones and/or aminoglycosides and/or cephalosporins were investigated phenotypically and genotypically for carbapenemases. A complete genome assembly (Illumina/Nanopore) was generated for the single isolate identified to investigate the genetic context for carbapenem resistance. RESULTS: One ST410 Escherichia coli isolate [(CARB35); 1/191, 0.5%], cultured from a wound in a springer spaniel, harboured a known carbapenem resistance gene (blaNDM-5). The gene was located in the chromosome on an integrated 100 kb IncF plasmid, also harbouring other drug resistance genes (mrx, sul1, ant1 and dfrA). The isolate also contained blaCMY-42 and blaTEM-190 on two separate plasmids (IncI1 and IncFII, respectively) that showed homology with other publicly available plasmid sequences from Italy and Myanmar. CONCLUSIONS: Even though the use of carbapenems in companion animals is restricted, the concurrent presence of blaCMY-42 and other antimicrobial resistance genes could lead to co-selection of carbapenemase genes in this population. Further studies investigating the selection and flow of plasmids carrying important resistance genes amongst humans and companion animals are needed.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Reynolds ME, Phan HTT, George S, et al. Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK. J Antimicrob Chemother. 2019. PMID: 30753576. doi:10.1093/jac/dkz017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。